ASMTL | Acetylserotonin O-methyltransferase-like | | | | | | Expressed in all |
CD99 | CD99 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
RAB9A | RAB9A, member RAS oncogene family | | | | | | Expressed in all |
SYAP1 | Synapse associated protein 1 | Predicted secreted proteins
| | | | | Expressed in all |
TXLNG | Taxilin gamma | | | | | | Expressed in all |
SH3KBP1 | SH3-domain kinase binding protein 1 | Cytoskeleton related proteins
| | | | | Expressed in all |
PRDX4 | Peroxiredoxin 4 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ACOT9 | Acyl-CoA thioesterase 9 | Mitochondrial proteins
| | | | | Expressed in all |
EIF2S3 | Eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa | Plasma proteins
| | | | | Expressed in all |
DYNLT3 | Dynein, light chain, Tctex-type 3 | Predicted secreted proteins
| | | | | Expressed in all |
ATP6AP2 | ATPase, H+ transporting, lysosomal accessory protein 2 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CXorf38 | Chromosome X open reading frame 38 | | | | | | Expressed in all |
CASK | Calcium/calmodulin-dependent serine protein kinase (MAGUK family) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
USP11 | Ubiquitin specific peptidase 11 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
UXT | Ubiquitously-expressed, prefoldin-like chaperone | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
FTSJ1 | FtsJ RNA methyltransferase homolog 1 (E. coli) | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
RBM3 | RNA binding motif (RNP1, RRM) protein 3 | Predicted secreted proteins
| | | | | Expressed in all |
WAS | Wiskott-Aldrich syndrome | Cancer-related genes Disease related genes
| | | | | Mixed |
PQBP1 | Polyglutamine binding protein 1 | Disease related genes
| | | | | Expressed in all |
PRAF2 | PRA1 domain family, member 2 | Predicted membrane proteins
| | | | | Expressed in all |
SYP | Synaptophysin | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GSPT2 | G1 to S phase transition 2 | | | | | | Expressed in all |
HSD17B10 | Hydroxysteroid (17-beta) dehydrogenase 10 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
HUWE1 | HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
MSN | Moesin | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
IGBP1 | Immunoglobulin (CD79A) binding protein 1 | Disease related genes
| | | | | Expressed in all |
PDZD11 | PDZ domain containing 11 | | | | | | Expressed in all |
NONO | Non-POU domain containing, octamer-binding | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
TAF1 | TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
PHKA1 | Phosphorylase kinase, alpha 1 (muscle) | Disease related genes
| | | | | Tissue enhanced |
SLC16A2 | Solute carrier family 16, member 2 (thyroid hormone transporter) | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
PGK1 | Phosphoglycerate kinase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
HMGN5 | High mobility group nucleosome binding domain 5 | Plasma proteins
| | | | | Expressed in all |
SH3BGRL | SH3 domain binding glutamic acid-rich protein like | Plasma proteins
| | | | | Expressed in all |
POF1B | Premature ovarian failure, 1B | Disease related genes
| | | | | Tissue enhanced |
CSTF2 | Cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa | Plasma proteins
| | | | | Expressed in all |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
HNRNPH2 | Heterogeneous nuclear ribonucleoprotein H2 (H') | | | | | | Expressed in all |
GPRASP2 | G protein-coupled receptor associated sorting protein 2 | | | | | | Mixed |
MORF4L2 | Mortality factor 4 like 2 | Plasma proteins
| | | | | Expressed in all |
FAM199X | Family with sequence similarity 199, X-linked | | | | | | Expressed in all |
MORC4 | MORC family CW-type zinc finger 4 | Cancer-related genes
| | | | | Tissue enhanced |
PSMD10 | Proteasome (prosome, macropain) 26S subunit, non-ATPase, 10 | | | | | | Expressed in all |
PGRMC1 | Progesterone receptor membrane component 1 | Predicted membrane proteins
| | | | | Expressed in all |
UPF3B | UPF3 regulator of nonsense transcripts homolog B (yeast) | Disease related genes
| | | | | Expressed in all |
LAMP2 | Lysosomal-associated membrane protein 2 | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CUL4B | Cullin 4B | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
SASH3 | SAM and SH3 domain containing 3 | | | | | | Tissue enhanced |
AIFM1 | Apoptosis-inducing factor, mitochondrion-associated, 1 | Disease related genes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
MBNL3 | Muscleblind-like splicing regulator 3 | | | | | | Tissue enhanced |